Abrahamsen J F, Smaaland R, Sothern R B, Laerum O D
Department of Pathology, Haukeland Hospital, University of Bergen, Norway.
Eur J Haematol. 1997 May;58(5):333-45. doi: 10.1111/j.1600-0609.1997.tb01680.x.
By use of a multiparameter flow cytometric method with specific surface markers, circadian (24-h) variations in cell cycle distribution have been studied in 19 healthy male volunteers by sampling bone marrow (BM) every 4-5 h during 24-h periods. Admixture of peripheral blood during the sampling was specifically adjusted for, and the fractions of cells in DNA synthetic phase were measured for different hemopoietic cell lineages. Significant circadian variations in DNA S-phase were demonstrated both in myelo- and erythropoiesis of the human BM, with 75% (myeloid) and 80% (erythroid) of the volunteers showing highest activity (values) of DNA S-phase during the day and lowest activity (values) between midnight and 04:00 h. A temporal relationship in the circadian variation of S-phase and G2/M-phase was demonstrated between the myeloid and erythroid cell lineages. The highest fractions of S-phase cells were found in erythropoiesis, while the highest circadian stage dependent variation was found in myelopoiesis. The existence of a similar phasing in DNA synthetic activity for myelopoietic and erythropoietic cells in the human bone marrow indicates that the circadian rhythmicity of hemopoiesis may be caused by a common regulatory mechanism. These findings may be relevant with regard to optimizing the use of cytotoxic drugs and hemopoietic growth factors by taking into consideration the intrinsic (endogenous) circadian variation in proliferative activity of human BM subpopulations.
通过使用一种带有特定表面标志物的多参数流式细胞术方法,对19名健康男性志愿者的细胞周期分布的昼夜(24小时)变化进行了研究。在24小时期间,每4 - 5小时采集一次骨髓(BM)样本。采样过程中对外周血的混入进行了专门调整,并测量了不同造血细胞谱系中处于DNA合成期的细胞比例。在人类骨髓的髓系和红系造血过程中均显示出DNA S期的显著昼夜变化,75%(髓系)和80%(红系)的志愿者在白天显示出DNA S期的最高活性(值),而在午夜至04:00之间活性(值)最低。在髓系和红系细胞谱系之间证明了S期和G2/M期昼夜变化的时间关系。在红系造血中发现处于S期细胞的比例最高,而在髓系造血中发现昼夜阶段依赖性变化最大。人类骨髓中髓系和红系细胞在DNA合成活性方面存在类似的相位表明,造血的昼夜节律性可能由共同的调节机制引起。这些发现对于通过考虑人类BM亚群增殖活性的内在(内源性)昼夜变化来优化细胞毒性药物和造血生长因子的使用可能具有相关性。